PAVIA stands for PhArmacoVIgilance Africa (PAVIA)

The project started in 2018 with a kick-off meeting in Dar es Salaam, Tanzania and ended with endline assessments in 2022 and a final webinar for researchers in 2023

PAVIA was a consortium that was funded by the European Developing countries Clinical Trials Partnership (EDCTP2 – grant number 1627 PAVIA CSA2016S). The PAVIA project aimed to strengthen pharmacovigilance in four African countries: Ethiopia, Nigeria, eSwatini, and Tanzania for the introduction of new drug a treatment regime for Multidrug-resistant Tuberculosis.